38I fundamentals
An in-depth look to Intellia Therapeutics Inc. operating, investing, and financing activities
38I free cash flow for Q1 24 is -114.15 M EUR. For 2023, 38I free cash flow was -369.72 M EUR and operating cash flow was -357.05 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM